De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Medical Disposables & Supplies Beheer

Beheer criteriumcontroles 2/4

De CEO Medical Disposables & Supplies' is Kurt Boothe, benoemd in Nov2020, heeft een ambtstermijn van 3.92 jaar. bezit rechtstreeks 19.44% van de aandelen van het bedrijf, ter waarde JMD 97.70M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4 jaar en 10.8 jaar.

Belangrijke informatie

Kurt Boothe

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.9yrs
Eigendom CEO	19.4%
Management gemiddelde ambtstermijn	4yrs
Gemiddelde ambtstermijn bestuur	10.8yrs

Recente managementupdates

Recent updates

CEO

Kurt Boothe

3.9yrs

Tenure

Mr. Kurt Boothe was a Company Secretary and General Manager of Medical Disposables & Supplies Limited until November 01, 2020 and serves as Executive Director. He serves as Chief Executive Officer of Medic...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kurt Boothe	CEO & Executive Director	3.9yrs	geen gegevens	19.44% JMD 112.0m
Myrtis Boothe	Founder & Executive Director	no data	geen gegevens	19% JMD 109.5m
Raymond Ernandez	Chief Financial Officer	no data	geen gegevens	geen gegevens
Bertino Gordon	Operations Manager	4.6yrs	geen gegevens	geen gegevens
Nadine Banton	Human Resource & Administrative Manager	4yrs	geen gegevens	geen gegevens
Kandise Morgan-Small	Sales & Marketing Manager	no data	geen gegevens	geen gegevens
Nikeisha Hill	Executive Director	no data	geen gegevens	19% JMD 109.5m

4.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van MDS wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kurt Boothe	CEO & Executive Director	no data	geen gegevens	19.44% JMD 112.0m
Myrtis Boothe	Founder & Executive Director	no data	geen gegevens	19% JMD 109.5m
Nikeisha Hill	Executive Director	no data	geen gegevens	19% JMD 109.5m
Vincent Lawrence	Lead Independent Director	10.8yrs	JA$613.75k	geen gegevens
Sheree Martin	Director	less than a year	geen gegevens	geen gegevens
Winston Boothe	Chairman	no data	JA$713.75k	19% JMD 109.5m
Dahlia McDaniel-Dickson	Independent Non-Executive Director	10.8yrs	JA$643.75k	0.55% JMD 3.2m

10.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MDS zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.8 jaar).

Medical Disposables & Supplies Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Medical Disposables & Supplies Limited Announces Board Appointments

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Medical Disposables & Supplies Limited Announces Board Appointments

Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023)

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur